Samueli Institute is a non-profit research organization supporting the scientific exploration of healing processes and their role in medicine, with the mission of transforming health care worldwide.
 
 
 

Pain-Related Research and Programs

Samueli Institute presented its ongoing pain research and planned future research specifically related to acupuncture to the Army Surgeon General’s Department of Defense (DoD) Pain Management Task Force (TF) by invitation in January 2010. Numerous areas of common interest were identified to advance the evidence base for integrative medicine (IM) approaches to pain in military populations. 

In this project, we will identify the most urgent and promising areas for research on integrative pain management approaches (other than acupuncture and mind-body medicine; see below) based on the needs identified in the Pain Management Task Force Final Report (May 2010) and Operation Order 10-76 (USAMEDCOM Comprehensive Pain Management Campaign Plan, September 2010). Our project team will work collaboratively with the Task Force to advance the state of the science in these areas.

The Task Force (TF) Final Report divided recommendations into four areas:
  1. Provide Tools and Infrastructure that Support and Encourage Practice and Research Advancements in Pain Management
  2. Build a Full Spectrum of Best Practices for the Continuum of Acute and Chronic Pain, Based on a Foundation of Best Available Evidence
  3. Focus on the Warrior and Family: Sustaining the Force
  4. Synchronize a Culture of Pain Awareness, Education, and Proactive Intervention

Included in the second recommendation area above, the Task Force addresses integrative medicine (IM) approaches with their objective to, “Incorporate integrative and alternative therapeutic modalities into a patient-centered plan of care;” (OTSG Pain Management Task Force Report, May 2010, p. E-5). Additionally, in laying out a path to move forward, the report specifically provides a mandate to study complementary and integrative medicine, noting: “The DoD should continue to responsibly explore safe and effective use of advanced and non-traditional approaches to pain management and support efforts to make these modalities covered benefits once they prove safe, effective and cost efficient;” (OTSG Pain Management Task Force Report, May 2010, p. E-3).

The projects listed below will employ an emerging research methodology designed to deliver patient outcomes data and cost benefit analysis in a real-world setting: comparative effectiveness research (CER). CER has been identified by both the U.S. Department of Health & Human Services (HHS) and the Institutes of Medicine (IOM) as a methodology that delivers beneficial information to both clinicians and patients regarding which treatment options best fit a patient’s needs and preferences in a real-world setting. This type of information will be invaluable to DoD policy leaders as the recommendations of the Task Force begin to be implemented into the pain management programs at Military Treatment Facilities across the country. CER can provide information on a patient’s preferences, outcomes, and associated costs all of which will become important factors in determining the success of these IM approaches. 

The overarching goal of the work done under the Integrative Pain Management research umbrella will be to illuminate what aspects of a program have the greatest impact and which ones contribute to successful outcomes. This work will also identify areas for improvement.

This work is supported by the US Army Medical Research and Materiel Command under Award Numbers:

W81XWH-08-2-0212
W81XWH-11-2-0173
W81XWH-08-1-0408
W81XWH-11-1-0759
W81XWH-10-1-0820
W81XWH-07-2-0076
W81XWH-06-1-0279
W81XWH-06-2-0009
W81XWH-10-1-1011
W81XWH-10-2-0184
W81XWH-08-1-0615
W81XWH-10-1-0938
W81XWH-11-1-0538

The views, opinions and/or findings contained in this report are those of the author(s) and should not be construed as an official Department of the Army position, policy or decision unless so designated by other documentation.

In the conduct of research where humans are the subjects, the investigator(s) adhered to the policies regarding the protection of human subjects as prescribed by Code of Federal Regulations (CFR) Title 45, Volume 1, Part 46; Title 32, Chapter 1, Part 219; and Title 21, Chapter 1, Part 50 (Protection of Human Subjects).